U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820657) titled 'EEG Theta Band Rhythm in SCS' on Sept. 03.
Brief Summary: We want to assess if reversal in EEG theta power during trial phase can serve as an objective marker for sustained clinical response, identifying true responders, and if the changes in EEG pattern during trial with three modalities can help in selection of SCS modality best suited to a given patient.
Study Start Date: June 16, 2022
Study Type: INTERVENTIONAL
Condition:
Chronic Neuropathic Pain
Intervention:
DEVICE: Reversal in EEG Theta Power
32 lead EEG at baseline, on day of surgery prior to trial lead implementation. Stimulation shall be started with high frequency...